ArticleBMC cancer2023

Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA).

Yuehong Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.